EDAP TMS Set for Key Presentations at Major Healthcare Conference
EDAP TMS SA (Nasdaq: EDAP), a pioneering force in the field of robotic energy-based therapies, has recently shared exciting news regarding its participation in an influential healthcare conference. The company's Chief Executive Officer, Ryan Rhodes, is set to take center stage at the Jefferies London Healthcare Conference, scheduled for November 19-21. This prestigious event attracts key players in the healthcare sector and offers valuable networking opportunities.
Event Details and Investor Engagement
During the conference, Rhodes will present to an audience of investors, highlighting EDAP TMS’s latest advancements and strategic vision. The presentation is scheduled for Tuesday, November 19, and will take place from 8:30 to 8:55 AM GMT at The Waldorf Hilton London.
In addition to the main presentation, Rhodes will also engage in one-on-one meetings with investors. This interaction is vital for fostering relationships and providing deeper insights into the company's market positioning and growth potential.
Live Webcast Access
For those unable to attend in person, a live and archived webcast of the presentation will be accessible through the Investors section of EDAP TMS’s website. The company values transparency and looks forward to sharing its progress with the broader investment community.
About EDAP TMS and Their Innovations
EDAP TMS SA has established itself as a leader within the global therapeutic ultrasound market. By focusing on minimally invasive medical technologies, the company develops and manufactures devices specifically aimed at treating various conditions using advanced ultrasound technology. Their flagship product, the Focal One, has significantly raised the bar for prostate tissue ablation and is now available in Europe and the U.S.
Moreover, EDAP TMS continues to innovate with its ExactVu™ Micro-Ultrasound device, representing the only complete solution that spans from diagnostics to focal treatment for prostate cancer. The company also provides a range of additional medical equipment, including the Sonolith® i-move lithotripter, which is utilized in treating urinary tract stones.
As EDAP TMS continues to enhance its product offerings and expand its presence in the healthcare sector, the company remains committed to providing cutting-edge solutions that prioritize patient care and therapeutic effectiveness.
Contact Information
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
Frequently Asked Questions
What is the Jefferies London Healthcare Conference?
The Jefferies London Healthcare Conference is a significant event that brings together investors and healthcare companies to discuss innovations and strategies in the sector.
When is EDAP TMS’s presentation at the conference?
EDAP TMS’s presentation is scheduled for Tuesday, November 19, from 8:30 to 8:55 AM GMT.
Who is the CEO of EDAP TMS?
The CEO of EDAP TMS is Ryan Rhodes, who will be presenting at the conference.
What products does EDAP TMS offer?
EDAP TMS offers various medical devices, including the Focal One for prostate tissue ablation and the ExactVu™ Micro-Ultrasound for prostate cancer diagnostics.
How can investors access the live webcast of EDAP TMS’s presentation?
Investors can access the live and archived webcast of the presentation through the Investors section of EDAP TMS’s website.
